Susquehanna International Group’s Cyclerion Therapeutics CYCN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Hold |
0
| – | – | – | 5741 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 6048 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 5696 |
|
|
2023
Q2 | – | Sell |
-2,259
| Closed | -$19.6K | – | 5791 |
|
|
2023
Q1 | $19.6K | Buy |
2,259
+1,306
| +137% | +$11.3K | ﹤0.01% | 5628 |
|
|
2022
Q4 | $12.5K | Sell |
953
-387
| -29% | -$5.08K | ﹤0.01% | 5445 |
|
|
2022
Q3 | $23K | Sell |
1,340
-258
| -16% | -$4.43K | ﹤0.01% | 5684 |
|
|
2022
Q2 | $18K | Buy |
1,598
+606
| +61% | +$6.83K | ﹤0.01% | 5427 |
|
|
2022
Q1 | $22K | Sell |
992
-404
| -29% | -$8.96K | ﹤0.01% | 5457 |
|
|
2021
Q4 | $48K | Sell |
1,396
-1,370
| -50% | -$47.1K | ﹤0.01% | 5476 |
|
|
2021
Q3 | $170K | Sell |
2,766
-1,243
| -31% | -$76.4K | ﹤0.01% | 4785 |
|
|
2021
Q2 | $313K | Buy |
4,009
+2,627
| +190% | +$205K | ﹤0.01% | 4415 |
|
|
2021
Q1 | $77K | Buy |
1,382
+281
| +26% | +$15.7K | ﹤0.01% | 5016 |
|
|
2020
Q4 | $67K | Buy |
1,101
+562
| +104% | +$34.2K | ﹤0.01% | 4576 |
|
|
2020
Q3 | $66K | Buy |
+539
| New | +$66K | ﹤0.01% | 4176 |
|
|
2020
Q1 | – | Sell |
-912
| Closed | -$50K | – | 4623 |
|
|
2019
Q4 | $50K | Buy |
912
+386
| +73% | +$21.2K | ﹤0.01% | 3778 |
|
|
2019
Q3 | $128K | Sell |
526
-64
| -11% | -$15.6K | ﹤0.01% | 4012 |
|
|
2019
Q2 | $135K | Buy |
+590
| New | +$135K | ﹤0.01% | 4061 |
|